Kroger discontinues needle-free flu vaccine offering
CINCINNATI — Kroger has discontinued offering needle-free clinical devices to administer flu vaccinations at all pharmacies and The Little Clinic locations.
Kroger said that its decision was based on guidance from the Food and Drug Administration that advised healthcare professionals not to use needle-free clinical devices to administer flu shots.
Kroger said it is seeking guidance from the Centers for Disease Control and the FDA regarding revaccinations.
FDA-approved vaccines have information in their labeling about how they should be administered, but doctors and other health professionals can opt for off-label use of medications if they believe it is in the best interest of their patientshttp://eng.am/vKYA5n This is a perfect example of the FDA working in the interests of Big Pharma and not the American public. The PharmaJet Jet Injector had been cleared for general use and its makers were coerced into pulling their product due to it's use with brand-name products. If it were dangerous at all, off-brand or on-brand it'd be outright banned. This is FDA working for profit.
You better watch out: ‘Flash robs’ loom this holiday season
NEW YORK — There’s one trend that retailers should brace for this holiday season.
Despite projected spending outlooks made by several research and retail groups, retailers nationwide will draw crowds this holiday season. However, it seems that certain consumers (particularly, teenagers and young adults) have utilized the power of technology and social media to conduct "flash robs," a take on the impromptu gatherings known as flash mobs.
Last week, the National Retail Federation released its 2011 crowd management guidelines, which warned retailers to be mindful of these events. According to an NRF Criminal Flash Mob report, 10% of retailers said they have been a victim of this type of multiple offender crime.
"Traditionally, these multiple offender crime groups engage in grab-and-run scenarios where offenders quickly enter stores and target specific merchandise — such as high-end handbags, jewelry and designer clothing — then flee, sometimes to a waiting vehicle or, as was the case in several high profile incidents, using mass transit," NRF said on its website.
"Many families make holiday shopping an important tradition, and retailers’ main goal is to make that experience a safe and pleasant one," said Joe LaRocca, NRF senior asset protection adviser Joe LaRocca said. "Crowd management is not taken lightly for retailers, who plan ahead for months in anticipation of large events with practice runs, a well-trained staff, and a thorough analysis of the company and its customers."
The Wall Street Journal also cited several instances of "flash robs," including one at a Philadelphia-area Sears over the summer, as well as several stores in Chicago. Affected retailers included Armani Exchange, Filene’s Basement and The North Face.
No comments found
Study: Fluzone High-Dose works well in senior population
SWIFTWATER, Pa. — Sanofi Pasteur, the vaccines division of Sanofi, released data from a new study examining the ability of its Fluzone High-Dose vaccine to provoke an immune response in elderly and younger adults, compared with a standard dose of Fluzone vaccine.
"The results further support the immunogenicity advantages of Fluzone High-Dose vaccine as compared to Fluzone vaccine, the standard dose comparator, in seniors 65 years of age and older," stated Peter Tsang, director clinical development, Sanofi Pasteur.
Fluzone High-Dose vaccine was licensed by the Food and Drug Administration in December 2009 for adults ages 65 years and older because the vaccine addressed an unmet medical need. People older than 65 years of age have the highest rates of hospitalization and death from influenza and its complications, despite having among the highest immunization rates against influenza. The immune response of people ages 65 years and older to the traditional flu shot is substantially lower than that of younger people. Thus, Fluzone High-Dose vaccine was developed to generate a more robust immune response in the senior population.
In the multicenter trial, 639 subjects between the ages of 65 and 96 were randomized to receive one standard dose of Fluzone vaccine or Fluzone High-Dose vaccine and 186 younger adults ages 18 through 49 years received Fluzone vaccine. Both influenza vaccines were formulated with the influenza virus strains for the 2007-2008 season and contained A/Solomon (H1N1), A/Wisconsin (H3N2) and B/Malaysia.
Hemagglutination Immunization antibody titers were measured before and 28 days post-vaccination.
Among those ages 65 years and older, statistically significantly higher antibody responses were induced by Fluzone High-Dose vaccine compared to Fluzone vaccine. Administration of Fluzone High-Dose vaccine in people over the age of 65 years enhanced the antibody response to levels similar to, and for some parameters higher than, those observed in younger adults receiving the standard dose of Fluzone vaccine.
The data were presented at the 49th Annual Meeting of the Infectious Diseases Society of America.
No comments found